ArticleOncotarget2014

Mislocalization of p27 to the cytoplasm of breast cancer cells confers resistance to anti-HER2 targeted therapy.

Hui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.